Information  X 
Enter a valid email address

Charles Stanley Grp (CAY)

  Print          Annual reports

Tuesday 28 April, 2020

Charles Stanley Grp

Disclosure of Rights attached to Equity Shares

RNS Number : 1391L
Charles Stanley Group PLC
28 April 2020

Charles Stanley Group PLC (the 'Company')


Disclosure of Rights attached to Equity Shares


In compliance with Listing Rule 9.2.6ER(1), the Company has forwarded to the Financial Conduct Authority, for publication, a copy of its Articles of Association, which is the document that sets out the terms and conditions on which its listed equity shares were issued.


A copy of the Articles of Association have been submitted to the National Storage Mechanism and will shortly be available for inspection at



Julie Ung

Company Secretary


Charles Stanley Group PLC LEI: 213800LBSEGKE5MCYC90



For further information, please contact:


Charles Stanley

Siobhan Griffiths

Head of Communications via KTZ Communications

Canaccord Genuity

David Tyrrell

020 7523 4677

Peel Hunt

Guy Wiehahn

020 7418 8893

KTZ Communications

Katie Tzouliadis

020 3178 6384

[email protected]

  Dan Mahoney

020 3178 6383

[email protected]



Notes to editors:


Charles Stanley traces its origins back directly to 1792 and is one of the oldest firms on the London Stock Exchange. Charles Stanley today provides holistic wealth management services to private clients, charities and smaller institutions. These are delivered by over 800 professionals located in 27 offices throughout the UK, both direct to clients and to intermediaries. Our services include investment portfolio management and financial planning, supported by in-house administration to enhance the quality of service provided.  In addition, Charles Stanley Direct provides an award winning direct to customer execution-only dealing platform for equities and funds.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t